AnalystsMatthew SheaMatthew Shea's Stock Forecasts
AnalystsMatthew Shea
Sectors:
Analyst Ranking
Top 30%
#1636 out of 5511 analysts
Average Return
+56.03%
Win Rate
75%6 out of 8
Risk vs Reward
Poor
Good
Matthew Shea's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Starling Oncology IncSTLN | +133.33% | $2.73 | $6.37 | 2026-03-09 - 2026-09-15 | Buy |
Starling Oncology IncSTLN | +124.30% | $2.84 | $6.37 | 2026-03-13 - 2026-09-15 | Buy |
Starling Oncology IncSTLN | +101.58% | $3.16 | $6.37 | 2025-11-25 - 2026-09-15 | Buy |
Astrana Health IncASTH | +63.40% | $23.47 | $38.35 | 2025-12-12 - 2026-09-15 | Buy |
Starling Oncology IncSTLN | +21.33% | $5.25 | $6.37 | 2026-06-17 - 2026-09-15 | Buy |
Matthew Shea Analyst Color
Get additional color on Matthew Shea's coverage of popular stocks
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.